Lorus Therapeutics, Inc. (AMEX: LRP)

Lorus Therapeutics, Inc. (AMEX: LRP), a biopharmaceutical company, is focused on discovering, researching and developing effective anticancer therapies with high safety profiles. By utilizing its own discovery efforts, in addition to acquisition and in-licensing programs, the company is building a portfolio of anticancer drugs ranging from discovery and preclinical to an advanced Phase II clinical trial. Each of the drug candidates in their current pipeline are backed by a strong intellectual property portfolio. For further information, visit the Company’s web site at www.lorusthera.com.